PMC:7652766 / 93051-93715 JSONTXT

{"project":"LitCovid-PD-HP","denotations":[{"id":"T131","span":{"begin":295,"end":304},"obj":"Phenotype"}],"attributes":[{"id":"A131","pred":"hp_id","subj":"T131","obj":"http://purl.obolibrary.org/obo/HP_0002090"}],"text":"Another double-blind, randomized, placebo-controlled trial of intravenous RDV conducted in adults hospitalized with COVID-19 with evidence of lower respiratory tract involvement was performed in different parts of the world (328). The study of Beigel and colleagues (328) enrolled 1,063 COVID19 pneumonia patients, 538 of whom were assigned to the treatment with RDV and 521 to a placebo, showed the effectiveness of RDV in treating COVID-19 patients. The drug was superior to the placebo in reducing the recovery time in hospitalized COVID-19 patients and decreased the mortality rate in the RDV group, however, this result did not reach statistical significance."}

{"project":"LitCovid-sentences","denotations":[{"id":"T455","span":{"begin":0,"end":230},"obj":"Sentence"},{"id":"T456","span":{"begin":231,"end":451},"obj":"Sentence"},{"id":"T457","span":{"begin":452,"end":664},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Another double-blind, randomized, placebo-controlled trial of intravenous RDV conducted in adults hospitalized with COVID-19 with evidence of lower respiratory tract involvement was performed in different parts of the world (328). The study of Beigel and colleagues (328) enrolled 1,063 COVID19 pneumonia patients, 538 of whom were assigned to the treatment with RDV and 521 to a placebo, showed the effectiveness of RDV in treating COVID-19 patients. The drug was superior to the placebo in reducing the recovery time in hospitalized COVID-19 patients and decreased the mortality rate in the RDV group, however, this result did not reach statistical significance."}

{"project":"LitCovid-PubTator","denotations":[{"id":"3427","span":{"begin":474,"end":476},"obj":"Gene"},{"id":"3428","span":{"begin":375,"end":377},"obj":"Gene"},{"id":"3429","span":{"begin":341,"end":343},"obj":"Gene"},{"id":"3430","span":{"begin":305,"end":313},"obj":"Species"},{"id":"3431","span":{"begin":442,"end":450},"obj":"Species"},{"id":"3432","span":{"begin":544,"end":552},"obj":"Species"},{"id":"3433","span":{"begin":148,"end":159},"obj":"Species"},{"id":"3434","span":{"begin":378,"end":379},"obj":"Gene"},{"id":"3435","span":{"begin":74,"end":77},"obj":"Chemical"},{"id":"3436","span":{"begin":363,"end":366},"obj":"Chemical"},{"id":"3437","span":{"begin":417,"end":420},"obj":"Chemical"},{"id":"3438","span":{"begin":593,"end":596},"obj":"Chemical"},{"id":"3439","span":{"begin":116,"end":124},"obj":"Disease"},{"id":"3440","span":{"begin":287,"end":304},"obj":"Disease"},{"id":"3441","span":{"begin":433,"end":441},"obj":"Disease"},{"id":"3442","span":{"begin":535,"end":543},"obj":"Disease"},{"id":"3443","span":{"begin":571,"end":580},"obj":"Disease"}],"attributes":[{"id":"A3427","pred":"tao:has_database_id","subj":"3427","obj":"Gene:6999"},{"id":"A3428","pred":"tao:has_database_id","subj":"3428","obj":"Gene:6999"},{"id":"A3429","pred":"tao:has_database_id","subj":"3429","obj":"Gene:6999"},{"id":"A3430","pred":"tao:has_database_id","subj":"3430","obj":"Tax:9606"},{"id":"A3431","pred":"tao:has_database_id","subj":"3431","obj":"Tax:9606"},{"id":"A3432","pred":"tao:has_database_id","subj":"3432","obj":"Tax:9606"},{"id":"A3433","pred":"tao:has_database_id","subj":"3433","obj":"Tax:12814"},{"id":"A3434","pred":"tao:has_database_id","subj":"3434","obj":"Gene:351"},{"id":"A3435","pred":"tao:has_database_id","subj":"3435","obj":"MESH:C000606551"},{"id":"A3436","pred":"tao:has_database_id","subj":"3436","obj":"MESH:C000606551"},{"id":"A3437","pred":"tao:has_database_id","subj":"3437","obj":"MESH:C000606551"},{"id":"A3438","pred":"tao:has_database_id","subj":"3438","obj":"MESH:C000606551"},{"id":"A3439","pred":"tao:has_database_id","subj":"3439","obj":"MESH:C000657245"},{"id":"A3440","pred":"tao:has_database_id","subj":"3440","obj":"MESH:C000657245"},{"id":"A3441","pred":"tao:has_database_id","subj":"3441","obj":"MESH:C000657245"},{"id":"A3442","pred":"tao:has_database_id","subj":"3442","obj":"MESH:C000657245"},{"id":"A3443","pred":"tao:has_database_id","subj":"3443","obj":"MESH:D003643"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Another double-blind, randomized, placebo-controlled trial of intravenous RDV conducted in adults hospitalized with COVID-19 with evidence of lower respiratory tract involvement was performed in different parts of the world (328). The study of Beigel and colleagues (328) enrolled 1,063 COVID19 pneumonia patients, 538 of whom were assigned to the treatment with RDV and 521 to a placebo, showed the effectiveness of RDV in treating COVID-19 patients. The drug was superior to the placebo in reducing the recovery time in hospitalized COVID-19 patients and decreased the mortality rate in the RDV group, however, this result did not reach statistical significance."}